Identifying the Right Investigators and Patients for your Study – Mini Podcast Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Check out our Assay List (Method Library)

Meet Veeda Group Experts at DCAT Week

21st to 24th March 2022

Veeda Group is delighted to participate in the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT).

We offer a broad range of services across most aspects of drug development and drug launch value-chain throughout the global markets. Our services include specialized services such as BA & BE studies, as well as a full suite of clinical trials including pre-clinical, early phase and late phase clinical trials, together with related services. In particular, we have expertise in PK studies as well as trials in complex generic molecules, NCEs, large molecules and biosimilars.

If you would like to arrange a meeting with our experts and discuss about your Drug Development requirements, feel free to fill the form and our team will be in touch with you shortly.

    Schedule a Meet Today!

    Veeda Group Experts participating at DCAT Week

    Mr Ajay Tandon

    Managing Director

    Mr Rajkumar Agarwal

    Head, Business Development

    Ms Cathy Lopez

    Sr. Director – Business Development

    Mr Pranav Kothari

    Sr. Manager – Business Development
    Book a Meeting